YB
Yasmeen Banu Ashfaq Risaldar
About Yasmeen Banu Ashfaq Risaldar
Data last updated:
Yasmeen Banu Ashfaq Risaldar has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Zeesquare Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Zeesquare Pharma Private Limited at ₹0.06 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zeesquare Pharma Private Limited U51909KA2021PTC148269 | Director | 08 Jun 2021 | 2021 | ₹0.06 Cr (FY 2023) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yasmeen Banu Ashfaq Risaldar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yasmeen Banu Ashfaq Risaldar
Yasmeen Banu Ashfaq Risaldar has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Zeesquare Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Zeesquare Pharma Private Limited at ₹0.06 Cr (FY 2023).
Yasmeen Banu Ashfaq Risaldar is associated with 1 company as Director, including Zeesquare Pharma Private Limited (₹0.06 Cr).
Yasmeen Banu Ashfaq Risaldar has expertise in General Business.
Yasmeen Banu Ashfaq Risaldar has 5 years in corporate governance.
By reported revenue, the largest current company of Yasmeen Banu Ashfaq Risaldar is Zeesquare Pharma Private Limited, with revenue of ₹0.06 Cr (FY 2023).
Yasmeen Banu Ashfaq Risaldar currently holds positions at 1 company: Zeesquare Pharma Private Limited (₹0.06 Cr).